VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 75 filers reported holding VAXCYTE INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $269,000 | -4.3% | 11,019 | -0.3% | 0.00% | – |
Q4 2021 | $281,000 | -1.7% | 11,056 | +1.1% | 0.00% | – |
Q3 2021 | $286,000 | +14.9% | 10,936 | +5.8% | 0.00% | – |
Q2 2021 | $249,000 | +37.6% | 10,339 | +18.5% | 0.00% | – |
Q1 2021 | $181,000 | -6.7% | 8,724 | +20.4% | 0.00% | – |
Q4 2020 | $194,000 | +340.9% | 7,243 | +758.2% | 0.00% | – |
Q3 2020 | $44,000 | – | 844 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $110,721,000 | 37.88% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $50,150,000 | 29.14% |
Pivotal bioVenture Partners Investment Advisor LLC | 2,222,970 | $59,064,000 | 19.47% |
FRAZIER MANAGEMENT LLC | 2,309,554 | $61,365,000 | 4.73% |
TPG Group Holdings (SBS) Advisors, Inc. | 4,941,213 | $131,288,000 | 1.46% |
RA Capital Management | 3,710,699 | $98,593,000 | 1.38% |
Foresite Capital Management IV, LLC | 465,821 | $12,377,000 | 1.34% |
Opaleye Management Inc. | 335,200 | $8,906,000 | 1.16% |
Novo Holdings A/S | 416,937 | $11,078,000 | 0.48% |
Affinity Asset Advisors, LLC | 30,000 | $797,000 | 0.42% |